These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
686 related articles for article (PubMed ID: 18768788)
1. A microRNA DNA methylation signature for human cancer metastasis. Lujambio A; Calin GA; Villanueva A; Ropero S; Sánchez-Céspedes M; Blanco D; Montuenga LM; Rossi S; Nicoloso MS; Faller WJ; Gallagher WM; Eccles SA; Croce CM; Esteller M Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13556-61. PubMed ID: 18768788 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671 [TBL] [Abstract][Full Text] [Related]
3. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Lujambio A; Portela A; Liz J; Melo SA; Rossi S; Spizzo R; Croce CM; Calin GA; Esteller M Oncogene; 2010 Dec; 29(48):6390-401. PubMed ID: 20802525 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261 [TBL] [Abstract][Full Text] [Related]
5. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
6. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach. Pavicic W; Perkiö E; Kaur S; Peltomäki P Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300 [TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
10. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Davalos V; Moutinho C; Villanueva A; Boque R; Silva P; Carneiro F; Esteller M Oncogene; 2012 Apr; 31(16):2062-74. PubMed ID: 21874049 [TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2. Tian Y; Wei W; Li L; Yang R Med Sci Monit; 2015 Dec; 21():3798-805. PubMed ID: 26638007 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma. Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228 [TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
17. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995 [TBL] [Abstract][Full Text] [Related]
18. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Augoff K; McCue B; Plow EF; Sossey-Alaoui K Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419 [TBL] [Abstract][Full Text] [Related]
20. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]